Clinical guide
DAST-10 Drug Screening Test: Questions, Scoring, Uses, and Limits
The DAST-10 is a self-report questionnaire about drug-related problems in the past 12 months; learn its questions, scoring, uses, and limits.
By Paul James Roeser·Reviewed by Noelle Mathew, LCSW, LCADC, CASAC-M·Last reviewed August 25, 2026·3 min read
Published ·Updated
The Drug Abuse Screening Test-10 (DAST-10) is a 10-item yes-or-no questionnaire about drug-related problems during the past 12 months. It excludes alcohol from its core focus, estimates the need for further evaluation, and does not diagnose a substance use disorder.
DAST-10 concentrates on consequences and problems related to drug use, while ASSIST covers alcohol, tobacco, and multiple drug categories and produces a separate risk score for each substance class.
What does the DAST-10 measure?
DAST-10 measures drug-related consequences, control problems, social effects, illegal activity connected with obtaining drugs, and withdrawal or medical concerns. Its questions refer to the previous 12 months, so the answers describe recent problems rather than a lifetime substance-use history.
The tool is intended for drug use other than alcohol. Instruments such as AUDIT or CAGE screen for alcohol-related concerns, which should not be inferred from a DAST-10 score.
What questions are on the DAST-10?
The ten DAST-10 items ask whether drug use has involved nonmedical use, multiple drugs, difficulty stopping, blackouts or flashbacks, relationship concerns, neglected responsibilities, illegal activity, withdrawal, or medical problems. The wording is brief so the questionnaire can be completed before a more detailed clinical conversation.
The person answers each item yes or no. The clinician should clarify the substance, timing, route, amount, prescription status, and consequences instead of treating one answer as a diagnosis.
How is the DAST-10 administered?
DAST-10 can be self-administered or delivered by a trained professional in primary care, behavioral-health, research, or treatment settings. It generally takes only a few minutes, but the follow-up assessment may take substantially longer.
Confidential administration improves disclosure, while literacy, language, stigma, legal concerns, and the person’s understanding of “drug” can change the result. The administering professional should explain what the score can and cannot show.
How is the DAST-10 scored?
Each DAST-10 response contributes one point under the instrument’s scoring rules, producing a total from 0 to 10. Common interpretation bands use the total to organize follow-up intensity, but the score is not a diagnosis or a stand-alone measure of treatment need.
| Total | Common interpretation | Clinical next step |
|---|---|---|
| 0 | No reported drug-related problems | Routine prevention and reassessment when indicated |
| 1–2 | Low level of problems | Clarify use and provide feedback |
| 3–5 | Moderate level of problems | Complete a fuller assessment |
| 6–8 | Substantial level of problems | Assess safety and treatment needs |
| 9–10 | Severe level of problems | Prompt comprehensive clinical evaluation |
A high score raises concern but does not establish severity under DSM criteria. Diagnosis requires a qualified clinician to review symptoms, duration, impairment, risk, medical history, and other explanations.
What happens after a positive DAST-10?
A positive DAST-10 leads to questions about the substances used, current safety, withdrawal, overdose exposure, mental health, and functional impairment. The follow-up may include brief intervention, harm-reduction education, diagnostic assessment, or referral according to the findings.
When the fuller assessment indicates a need for structured support, the need for drug or alcohol rehab is decided from clinical risk and level-of-care needs, not from the DAST-10 total alone.
How does DAST-10 differ from ASSIST and CRAFFT?
DAST-10 is a past-year drug-problem screen; ASSIST compares risk across many substance categories; CRAFFT is a youth-focused screen that includes riding or driving risk. Selecting among them depends on age, substance scope, setting, and the next service available.
The DAST-10 should not be used as a substitute for the CRAFFT when screening an adolescent population, and its drug-only focus does not answer an alcohol-screening question.
What are the limitations of the DAST-10?
DAST-10 is limited by self-report error, ambiguous substance terminology, recall problems, cultural context, and its inability to measure intoxication or biological exposure. It also does not independently assess alcohol, nicotine, psychiatric symptoms, medical instability, or withdrawal severity.
A negative result does not end evaluation when a person has urgent symptoms or credible reports of harm. A positive result is a reason to ask better clinical questions, not a reason to assign a diagnosis automatically.
Sources & References2ShowHide
- National Institute on Drug Abuse Data Share. Drug Abuse Screening Test, accessed August 25, 2026 — Describes the DAST-10 as a brief drug-focused screening instrument and identifies its clinical-trial use.
- SAMHSA. TIP 63: Medications for Opioid Use Disorder, accessed August 25, 2026 — Supports the distinction between a screening result, further assessment, and treatment planning.